Get the Stockscreener App
41.78
0.41%
-0.17
After Hours:
41.78
Xoma Royalty Corp stock is traded at $41.78, with a volume of 133.63K.
It is down -0.41% in the last 24 hours and up +0.07% over the past month.
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates. The Company's drug royalty aggregator business is mainly focused on the acquisition of early to mid-stage clinical assets. Geographically, the company operates in Switzerland, the United States, Asia Pacific, Europe, and other regions.
See More
Previous Close:
$41.95
Open:
$41.94
24h Volume:
133.63K
Relative Volume:
0.65
Market Cap:
$738.62M
Revenue:
$48.56M
Net Income/Loss:
$25.56M
P/E Ratio:
26.59
EPS:
1.5712
Net Cash Flow:
$-14.09M
1W Performance:
-0.41%
1M Performance:
+0.07%
6M Performance:
+61.75%
1Y Performance:
+72.15%
1-Day Range:
$41.78
$42.07
1-Week Range:
$41.65
$42.20
52-Week Range:
$22.29
$42.81
Xoma Royalty Corp Stock (XOMA) Company Profile
Name
Xoma Royalty Corp
Sector
Industry
Phone
510-204-7239
Address
2200 POWELL STREET, EMERYVILLE, CA
Compare XOMA vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XOMA
Xoma Royalty Corp
|
41.78 | 741.62M | 48.56M | 25.56M | -14.09M | 1.5712 |
VRTX
Vertex Pharmaceuticals Inc
|
453.17 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
614.73 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
878.49 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
281.90 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
156.58 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Xoma Royalty Corp Stock (XOMA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-17-25 | Initiated | The Benchmark Company | Buy |
| Apr-29-24 | Initiated | Leerink Partners | Outperform |
| Sep-07-21 | Downgrade | Wedbush | Outperform → Neutral |
| Jun-29-21 | Initiated | Aegis Capital | Buy |
| Jan-19-21 | Reiterated | H.C. Wainwright | Buy |
| Jan-18-18 | Reiterated | H.C. Wainwright | Buy |
| Oct-17-17 | Resumed | H.C. Wainwright | Buy |
| Sep-05-17 | Upgrade | Wedbush | Neutral → Outperform |
| Jun-12-17 | Initiated | H.C. Wainwright | Buy |
| Nov-14-16 | Downgrade | Wedbush | Outperform → Neutral |
| Mar-11-16 | Reiterated | Wedbush | Outperform |
| Jul-23-15 | Downgrade | Jefferies | Buy → Hold |
| Jul-22-15 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Jul-22-15 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Oct-10-14 | Resumed | ROTH Capital | Buy |
| Apr-29-14 | Upgrade | MLV & Co | Hold → Buy |
| Mar-11-14 | Downgrade | MLV & Co | Buy → Hold |
| Mar-05-14 | Reiterated | Ladenburg Thalmann | Buy |
| Oct-31-13 | Reiterated | MLV & Co | Buy |
| May-09-13 | Reiterated | Ladenburg Thalmann | Buy |
| May-14-12 | Initiated | Cowen & Co | Outperform |
| Mar-31-11 | Reiterated | MLV Capital | Buy |
| Mar-23-11 | Reiterated | RBC Capital Mkts | Outperform |
| Jan-06-11 | Reiterated | Ladenburg Thalmann | Buy |
| Jan-04-11 | Reiterated | Wedbush | Outperform |
View All
Xoma Royalty Corp Stock (XOMA) Latest News
XOMA Corp8.375% DP PFD B declares $0.5234 dividend - MSN
XOMA Royalty Corp Declares Preferred Stock Dividend, Announces Redemption and CVR Record Date Ahead of Ligand Merger – Minichart - Minichart
XOMA Details Merger Timeline and Preferred Share Redemption - TipRanks
XOMA Royalty (XOMA) Holds Steady Near $42 as Trading Range Remains IntactPCR Extreme - newsline.com
XOMA Royalty expects HoldCo acquisition to close ~July 14; redeems preferred stock - TradingView
XOMA (XOMA) to redeem all preferred shares and issue CVRs ahead of Ligand deal - Stock Titan
XOMA Royalty Corporation Declares Quarterly Preferred Stock Dividend and Announces Redemption of Its Perpetual Preferred Stock and CVR Dividend Record Date - The Manila Times
Investors in XOMA face preferred stock redemption, new CVR rights - Stock Titan
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger-TMHC, CZR, XOMA, and RAMP - The Malaysian Reserve
XOMA Royalty Sets July Vote on $39-per-Share Ligand Takeover and Reorganization - TipRanks
Ligand to Buy XOMA Royalty (NASDAQ: XOMA) for $39.00 Cash Plus CVR - Stock Titan
XOMA Royalty Holds Steady Near Support Levels After Modest GainDividend Stock Picks - newsline.com
XOMA Royalty Holds Steady Near $42 as Resistance at $44.28 LoomsMFI Oversold - newsline.com
Ligand set to report earnings as XOMA deal reshapes growth outlook - Investing.com
XOMA (XOMA) Q4 2025 Earnings Call Transcript - AOL.com
XOMA ROYALTY CORPXOMA 8 5/8 PERP (XOMAP) Stock Price & Overview - ChartMill
[Form 4] XOMA Royalty Corp Insider Trading Activity - Stock Titan
Director at XOMA (XOMA) granted 3,586 RSUs vesting over 12 months - Stock Titan
Director at XOMA (NASDAQ: XOMA) granted 3,586 RSUs vesting over 12 months - Stock Titan
XOMA Royalty Corp (XOMA) director receives 3,586 RSU equity grant - Stock Titan
Equity grant: XOMA (XOMA) director awarded 3,586 RSUs of common stock - Stock Titan
XOMA Royalty (XOMA) merger: $39.00 cash + one CVR tied to Janssen litigation - Stock Titan
XOMAP Q1 2026 Earnings: EPS Misses Estimates Amid Ongoing Royalty FluctuationsBasic EPS Analysis - thelegaladvocate.com
Saying Goodbye To The XOMA Royalty PFDs (NASDAQ:XOMAO) - Seeking Alpha
XOMA Royalty Corporation (Formerly XOMA Corp) Files Form 8-K Detailing Bylaws Amendments and Stock Awards – May 2026 - Minichart
XOMA Royalty shareholders approve incentive plan amendments and bylaw changes By Investing.com - Investing.com South Africa
XOMA Royalty shareholders approve incentive plan amendments and bylaw changes - Investing.com UK
XOMA (NASDAQ: XOMA) shareholders approve equity plans and new bylaw provisions - Stock Titan
XOMAO Stock Price and Chart — NASDAQ:XOMAO - TradingView
BVF group (NASDAQ: XOMA) converts 5,003 Series X preferred into common - Stock Titan
BVF group boosts XOMA (XOMA) ownership to 43.3% after Series X share conversion - Stock Titan
XOMA Royalty amends merger agreement with Ligand Pharmaceuticals By Investing.com - Investing.com Canada
Ligand Pharmaceuticals Files 8-K Announcing Amendment No. 1 to Agreement and Plan of Merger with XOMA Royalty Corporation 10 - Minichart
XOMA Royalty Corp Announces SEC Filing for Merger Agreement with Ligand Pharmaceuticals - Minichart
XOMA Royalty amends merger agreement with Ligand Pharmaceuticals - Investing.com
Ligand Pharmaceuticals amends merger agreement with XOMA Royalty Corporation By Investing.com - Investing.com Canada
Ligand Pharmaceuticals amends merger agreement with XOMA Royalty Corporation - Investing.com
XOMA Royalty Amends Ligand Merger Agreement, Adding Holding Company to Advance Acquisition - TradingView
XOMA Royalty (XOMA) adds new holding company to structure of Ligand acquisition - Stock Titan
Ligand (NASDAQ: LGND) amends XOMA Royalty merger, adds Nevada holding company - Stock Titan
XOMA royalty (XOMA) price target decreased by 32.32% to 45.39 - MSN
Woodline (XOMA) reports 640,001-share, 5.4% passive stake in XOMA Royalty - Stock Titan
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Veris Residential, Inc. (NYSE – VRE), XOMA Royalty Corporation (Nasdaq – XOMA), Organon & Co. (NYSE – OGN), RE/MAX Holdings, Inc. (NYSE – RMAX) - GlobeNewswire Inc.
XOMA ROYALTY CORP (NASDAQ:XOMAP) Passes Navellier’s Little Book Growth Screen with Strong Momentum - ChartMill
Ligand-Xoma Deal Would Combine Two Royalty Aggregators -- WSJ - Moomoo
TradingKey - TradingKey
Q1 2026: XOMA (NASDAQ: XOMA) profit rises to $4.5M on royalty income - Stock Titan
XOMA Royalty Corporation (NASDAQ:XOMA) Checks Nearly Every Box in Louis Navellier’s Eight-Rule Growth Stock Screen - ChartMill
XOMA Royalty Corporation (NASDAQ:XOMA) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
How XOMA (XOMAO) management quality drives results (Trend Strengthens) 2026-05-08Volatility Smirk - newsline.com
Xoma Royalty Corp Stock (XOMA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Xoma Royalty Corp Stock (XOMA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Montano Maricel Perea | Chief Legal Officer |
Apr 20 '26 |
Option Exercise |
0.00 |
3,370 |
0 |
41,793 |
| Hughes Owen | Chief Executive Officer |
Apr 20 '26 |
Option Exercise |
0.00 |
10,568 |
0 |
191,264 |
| Sitko Bradley | Chief Investment Officer |
Apr 20 '26 |
Option Exercise |
0.00 |
3,737 |
0 |
82,961 |
| Trigilio Jeffrey | Chief Financial Officer |
Apr 13 '26 |
Option Exercise |
0.00 |
4,000 |
0 |
94,000 |
| LIMBER JOSEPH M | Director |
Mar 27 '26 |
Option Exercise |
11.20 |
3,026 |
33,891 |
9,234 |
| WYSZOMIERSKI JACK L | Director |
Mar 24 '26 |
Option Exercise |
11.20 |
3,026 |
33,891 |
21,530 |
| Hughes Owen | Chief Executive Officer |
Dec 04 '25 |
Buy |
25.05 |
100,000 |
2,505,000 |
102,000 |
| Sitko Bradley | Chief Investment Officer |
Sep 19 '25 |
Option Exercise |
0.00 |
6,712 |
0 |
19,822 |
| Hughes Owen | Chief Executive Officer |
Sep 19 '25 |
Option Exercise |
0.00 |
35,567 |
0 |
98,268 |
| BURNS THOMAS M. | SVP, Finance & CFO |
Sep 19 '25 |
Option Exercise |
0.00 |
11,846 |
0 |
34,409 |
1.27%
1.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):